Stay updated with breaking news from D rated medical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tighter lending standards and high interest rates will likely push the economy into a recession this year. Therefore, it could be wise to sell fundamentally weak stocks Owens & Minor. ....
Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE), before. ....